Treatment of infantile hemangiomas before and after the introduction of propranolol: a retrospective study
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Propranolol was introduced as systemic pharmacotherapy for problematic hemangiomas in 2008 and is now considered superior to corticosteroid. Other available treatment modalities include surgery and laser therapy. In November 2008, the first patient was treated with propranolol at The Center for Vascular Anomalies, Aarhus University Hospital. The aim of this study was to compare the treatment modalities applied before and after the actual date.
The present study was a retrospective study of patients treated for hemangioma between 1995 and 2012 at the University Hospital of Aarhus, Denmark. Outcome measures of interest included age at referral, the extent of evaluation by different specialties, and the treatments administered.
One hundred twenty-one patients were included in the study. The patients were divided into two groups, patients treated before (study period 1) and after (study period 2) November 2008, respectively. In study period 2, patients were referred earlier for evaluation (0.82 versus 1.91 years, p = 0.011). Fewer patients were seen by plastic surgeons in study period 2 (63.9 versus 98.8 %, p < 0.001), with more patients being referred for systemic treatment (12.9 versus 86.1 %, p < 0.001). No difference in the number of patients evaluated by dermatologists was detected (p = 0.417). In study period 2, fewer patients were treated with surgery (38.9 versus 92.2, p < 0.001) and laser therapy (13.9 versus 42.4, p = 0.003). After November 2008, more patients have been treated with systemic pharmacotherapy (4.7 versus 80.6 %, p < 0.001).
The introduction of propranolol has resulted in a decline in surgery and laser therapy at our institution. More patients are being referred for systemic pharmacotherapy due to the treatment protocol of propranolol.
Level of Evidence: Level IV, therapeutic study.
- Kilcline C, Frieden IJ (2008) Infantile hemangiomas: how common are they? A systematic review of the medical literature. Pediatr Dermatol 25:168–173 CrossRef
- Haggstrom AN, Drolet BA, Baselga E et al (2007) Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr 150:291–294 CrossRef
- Chen TS, Eichenfield LF, Friedlander SF (2013) Infantile hemangiomas: an update on pathogenesis and therapy. Pediatrics 131:99–108 CrossRef
- Leaute-Labreze C, Dumas de la Roque E, Hubiche T et al (2008) Propranolol for severe hemangiomas of infancy. N Engl J Med 358:2649–2651 CrossRef
- Izadpanah A, Izadpanah A, Kanevsky J et al (2013) Propranolol versus corticosteroids in the treatment of infantile hemangioma: a systematic review and meta-analysis. Plast Reconstr Surg 131:601–613 CrossRef
- Chamlin SL, Haggstrom AN, Drolet BA et al (2007) Multicenter prospective study of ulcerated hemangiomas. J Pediatr 151:684–689 CrossRef
- Phillips RJ, Penington AJ, Bekhor PS et al (2012) Use of propranolol for treatment of infantile haemangiomas in an outpatient setting. J Paediatr Child Health 48:902–906 CrossRef
- Arneja JS, Chim H, Drolet BA et al (2010) The Cyrano nose: refinements in surgical technique and treatment approach to hemangiomas of the nasal tip. Plast Reconstr Surg 126:1291–1299 CrossRef
- Hynes S, Narasimhan K, Courtemanche DJ et al (2013) Complicated infantile hemangioma of the lip: outcomes of early versus late resection. Plast Reconstr Surg 131:373–379 CrossRef
- Storch CH, Hoeger PH (2010) Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol 163:269–274 CrossRef
- Wong A, Hardy KL, Kitajewski AM et al (2012) Propranolol accelerates adipogenesis in hemangioma stem cells and causes apoptosis of hemangioma endothelial cells. Plast Reconstr Surg 130:1012–1021 CrossRef
- Katona G, Csákányi Z, Gács E et al (2012) Propranolol for infantile haemangioma: striking effect in the first weeks. Int J Pediatr Otorhinolaryngol 76:1746–1750 CrossRef
- de Graff M, Raphael MF, Breugem CC et al (2013) Treatment of infantile hemangiomas with atenolol: comparison with a historical propranolol group. J Plast Reconstr Aesthet Surg 8:1–9
- Zvulunov A, McCuaig C, Frieden IJ et al (2011) Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study. Pediatr Dermatol 28:94–98 CrossRef
- Treatment of infantile hemangiomas before and after the introduction of propranolol: a retrospective study
European Journal of Plastic Surgery
Volume 37, Issue 4 , pp 195-200
- Cover Date
- Print ISSN
- Online ISSN
- Springer Berlin Heidelberg
- Additional Links
- Vascular tumour
- Laser therapy
- Industry Sectors
- Author Affiliations
- 1. Department of Plastic Surgery and Reconstruction, Aarhus University Hospital, Nørrebrogade 44, 8000, Aarhus, Denmark
- 2. Department of Plastic Surgery and Reconstruction, Odense University Hospital, Odense, Denmark
- 3. Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark